Feb 18 (Reuters) - Aap Implantate AG AAQG.DE :
* Sales forecast for FY/2016 between 30 million euros and
34 million euros ($33 million - $38 million)
* Sees EBITDA of 0.0 million euros to 1.0 million euros for
financial year 2016
* Outlook for financial year 2016: aims for more than 20
pct trauma sales growth
* Cost reduction planned in all divisions except sales
* For Q1 of 2016 management board anticipates sales of 4.5
million euros to 6.0 million euros and an EBITDA of -2.0 million
euros to -1.0 million euros
Source text for Eikon: ID:nHUG3g1SXl
Further company coverage: AAQG.DE
($1 = 0.9026 euros)
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 39 20;))